Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart.
Model: Doxorubicin-induced acute cardiotoxicity (single intraperitoneal dose of 20 mg/kg doxorubicin); pharmacokinetic experiments used a single intravenous 5 mg/kg doxorubicin dose
Scutellarin co-treatment reduced LDH activity from 4057.8 to 2595.9, malondialdehyde from 2.083 to 1.380 nmol/mg protein and cardiac troponin T from 0.1695 to 0.0222 ng/mL, and raised LVEF from 47.75 to 76.70% and LVFS from 20.66 to 40.28%, with markedly reduced cardiac histological damage. It lowe…
Extraction: extract · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.